These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16211527)

  • 1. Hemofiltration for cytokine-driven illnesses: the mediator delivery hypothesis.
    Di Carlo JV; Alexander SR
    Int J Artif Organs; 2005 Aug; 28(8):777-86. PubMed ID: 16211527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood and plasma treatments: the rationale of high-volume hemofiltration.
    Honoré PM; Joannes-Boyau O; Gressens B
    Contrib Nephrol; 2007; 156():387-95. PubMed ID: 17464149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration.
    Heering P; Morgera S; Schmitz FJ; Schmitz G; Willers R; Schultheiss HP; Strauer BE; Grabensee B
    Intensive Care Med; 1997 Mar; 23(3):288-96. PubMed ID: 9083231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients.
    Bellomo R; Tipping P; Boyce N
    Crit Care Med; 1993 Apr; 21(4):522-6. PubMed ID: 8472571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments.
    Tetta C; Mariano F; Buades J; Ronco C; Wratten ML; Camussi G
    Am J Kidney Dis; 1997 Nov; 30(5 Suppl 4):S57-65. PubMed ID: 9372980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Super high-flux' or 'high cut-off' hemofiltration and hemodialysis.
    Naka T; Haase M; Bellomo R
    Contrib Nephrol; 2010; 166():181-189. PubMed ID: 20473007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of hemofiltration with PEPA membrane for IL-6 removal in a rat sepsis model.
    Maeda H; Tomisawa N; Jimbo Y; Harii N; Matsuda K
    J Artif Organs; 2017 Dec; 20(4):335-340. PubMed ID: 28894963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-3 and -8 activation and cytokine removal with a novel cellulose triacetate super-permeable membrane in an in vitro sepsis model.
    Bordoni V; Bolgan I; Brendolan A; Crepaldi C; Gastaldon F; D'intini V; Pilotto L; Inguaggiato P; Bonello M; Galloni E; Everard P; Bellomo R; Ronco C
    Int J Artif Organs; 2003 Oct; 26(10):897-905. PubMed ID: 14636005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is cytokine removal by continuous hemofiltration feasible?
    Sieberth HG; Kierdorf HP
    Kidney Int Suppl; 1999 Nov; (72):S79-83. PubMed ID: 10560812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances.
    Hoffmann JN; Hartl WH; Deppisch R; Faist E; Jochum M; Inthorn D
    Kidney Int; 1995 Nov; 48(5):1563-70. PubMed ID: 8544415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design.
    Honoré PM; Matson JR
    Crit Care; 2002 Oct; 6(5):394-6. PubMed ID: 12398774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemofiltration during severe sepsis or multiorgan failure syndrome].
    Guenoun T; Journois D; Safran D
    Nephrologie; 1998; 19(2):83-8. PubMed ID: 9592778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Efficiency Removal of Cytokines and HMGB-1 by Continuous Hemofiltration With a Dual Layered Polyethersulfone Membrane: An Ex Vivo Study.
    Ohchi Y; Goto K; Yasuda N; Koga H; Kitano T
    Ther Apher Dial; 2019 Apr; 23(2):173-179. PubMed ID: 30306713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine removal in septic patients with continuous venovenous hemofiltration.
    Heering P; Grabensee B; Brause M
    Kidney Blood Press Res; 2003; 26(2):128-34. PubMed ID: 12771539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemofiltrate from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compounds.
    Hoffmann JN; Werdan K; Hartl WH; Jochum M; Faist E; Inthorn D
    Shock; 1999 Sep; 12(3):174-80. PubMed ID: 10485594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of mediators by continuous hemofiltration in septic patients.
    Hoffmann JN; Faist E
    World J Surg; 2001 May; 25(5):651-9. PubMed ID: 11369995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th17/regulatory T cell imbalance in sepsis patients with multiple organ dysfunction syndrome: attenuated by high-volume hemofiltration.
    Guo J; Tao W; Tang D; Zhang J
    Int J Artif Organs; 2017 Oct; 40(11):607-614. PubMed ID: 28731485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator.
    Nakamura M; Oda S; Sadahiro T; Hirayama Y; Watanabe E; Tateishi Y; Nakada TA; Hirasawa H
    Contrib Nephrol; 2010; 166():73-82. PubMed ID: 20472994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of endogenous pyrogens across artificial membranes?
    Lonnemann G; Linnenweber S; Burg M; Koch KM
    Kidney Int Suppl; 1998 May; 66():S43-6. PubMed ID: 9573572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.
    Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM
    Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.